Insider Trading Alert - PRXL, CNBKA And FOXF Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 15, 2014, 114 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $538.00 to $2,081,081.25.

Highlighted Stocks Traded by Insiders:

Parexel International (PRXL) - FREE Research Report

Tsuetaki Tracy Ken, who is SVP, PCMS and PACE at Parexel International, bought 455 shares at $54.47 on Dec. 15, 2014. Following this transaction, the SVP, PCMS and PACE owned 3,455 shares meaning that the stake was boosted by 15.17% with the 455-share transaction.

The shares most recently traded at $53.10, down $1.37, or 2.57% since the insider transaction. Historical insider transactions for Parexel International go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 12,000
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 12,000
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 24,800

The average volume for Parexel International has been 738,400 shares per day over the past 30 days. Parexel International has a market cap of $3.0 billion and is part of the health care sector and health services industry. Shares are up 19.81% year-to-date as of the close of trading on Friday.

PAREXEL International Corporation is a biopharmaceutical outsourcing services company. The company has a P/E ratio of 22.3. Currently, there are 6 analysts who rate Parexel International a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PRXL - FREE

TheStreet Quant Ratings rates Parexel International as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Parexel International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Century Bancorp (CNBKA) - FREE Research Report

Filler James J, who is 10% Owner at Century Bancorp, bought 127 shares at $39.46 on Dec. 15, 2014. Following this transaction, the 10% Owner owned 388,991 shares meaning that the stake was boosted by 0.03% with the 127-share transaction.

The shares most recently traded at $39.35, down $0.11, or 0.28% since the insider transaction. Historical insider transactions for Century Bancorp go as follows:

  • 4-Week # shares bought: 9
  • 12-Week # shares bought: 30
  • 24-Week # shares bought: 71

The average volume for Century Bancorp has been 5,100 shares per day over the past 30 days. Century Bancorp has a market cap of $144.2 million and is part of the financial sector and banking industry. Shares are up 18.8% year-to-date as of the close of trading on Friday.

Century Bancorp, Inc. operates as the bank holding company for Century Bank and Trust Company that provides banking products and services to commercial enterprises, state and local governments and agencies, nonprofit organizations, and individuals in Massachusetts. The stock currently has a dividend yield of 1.2%. The company has a P/E ratio of 10.5.

Exclusive Offer: Get the latest Stock Analysis on CNBKA - FREE

TheStreet Quant Ratings rates Century Bancorp as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, expanding profit margins, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Century Bancorp Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Fox Factory (FOXF) - FREE Research Report

Sabo Elias, who is Director at Fox Factory, bought 35,033 shares at $14.67 on Dec. 15, 2014. Following this transaction, the Director owned 117,758 shares meaning that the stake was boosted by 42.35% with the 35,033-share transaction.

The shares most recently traded at $15.23, up $0.56, or 3.68% since the insider transaction. Historical insider transactions for Fox Factory go as follows:

  • 4-Week # shares bought: 82,725
  • 4-Week # shares sold: 25,000
  • 12-Week # shares bought: 82,725
  • 12-Week # shares sold: 123,000
  • 24-Week # shares bought: 82,725
  • 24-Week # shares sold: 5.4 million

The average volume for Fox Factory has been 158,000 shares per day over the past 30 days. Fox Factory has a market cap of $542.9 million and is part of the consumer goods sector and automotive industry. Shares are down 13.68% year-to-date as of the close of trading on Friday.

Fox Factory Holding Corp designs, engineers, manufactures, and markets suspension products for mountain bikes, side-by-side vehicles, on-road and off-road vehicles and trucks, all-terrain vehicles, snowmobiles, specialty vehicles and applications, and motorcycles. The company has a P/E ratio of 18.5. Currently, there are 4 analysts who rate Fox Factory a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FOXF - FREE

TheStreet Quant Ratings rates Fox Factory as a hold. The company's strengths can be seen in multiple areas, such as its notable return on equity, revenue growth and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and poor profit margins. Get the full Fox Factory Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

AMD Rises Above the Competition; Loan Losses Mount for Big Banks -- ICYMI

AMD Rises Above the Competition; Loan Losses Mount for Big Banks -- ICYMI

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb

Why Nashville, Denver, LA Should Reconsider Bids for Amazon HQ2

Why Nashville, Denver, LA Should Reconsider Bids for Amazon HQ2